title: Srv mediated dispersal of streptococcal biofilms through SpeB is observed in CovRS+ strains.
abstract: Group A Streptococcus (GAS) is a human specific pathogen capable of causing both mild infections and severe invasive disease. We and others have shown that GAS is able to form biofilms during infection. That is to say, they form a three-dimensional, surface attached structure consisting of bacteria and a multi-component extracellular matrix. The mechanisms involved in regulation and dispersal of these GAS structures are still unclear. Recently we have reported that in the absence of the transcriptional regulator Srv in the MGAS5005 background, the cysteine protease SpeB is constitutively produced, leading to increased tissue damage and decreased biofilm formation during a subcutaneous infection in a mouse model. This was interesting because MGAS5005 has a naturally occurring mutation that inactivates the sensor kinase domain of the two component regulatory system CovRS. Others have previously shown that strains lacking covS are associated with decreased SpeB production due to CovR repression of speB expression. Thus, our results suggest the inactivation of srv can bypass CovR repression and lead to constitutive SpeB production. We hypothesized that Srv control of SpeB production may be a mechanism to regulate biofilm dispersal and provide a mechanism by which mild infection can transition to severe disease through biofilm dispersal. The question remained however, is this mechanism conserved among GAS strains or restricted to the unique genetic makeup of MGAS5005. Here we show that Srv mediated control of SpeB and biofilm dispersal is conserved in the invasive clinical isolates RGAS053 (serotype M1) and MGAS315 (serotype M3), both of which have covS intact. This work provides additional evidence that Srv regulated control of SpeB may mediate biofilm formation and dispersal in diverse strain backgrounds.
authors.affiliation: Department of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America.
authors.forename: Kristie L
authors.initials: KL
authors.lastname: Connolly
authors.forename: Amy K
authors.initials: AK
authors.lastname: Braden
authors.forename: Robert C
authors.initials: RC
authors.lastname: Holder
authors.forename: Sean D
authors.initials: SD
authors.lastname: Reid
mesh_terms: D000818:Animals; D001426:Bacterial Proteins / Q000378:metabolism / Q000502:physiology*; D018441:Biofilms; D002448:Cell Adhesion; D057056:Cysteine Proteases / Q000737:chemistry; D005098:Exotoxins / Q000378:metabolism / Q000502:physiology*; D005260:Female; D005786:Gene Expression Regulation; D015964:Gene Expression Regulation, Bacterial; D005840:Gentian Violet / Q000494:pharmacology; D051379:Mice; D008812:Mice, Hairless; D009154:Mutation; D017434:Protein Structure, Tertiary; D013234:Stem Cells; D013290:Streptococcal Infections / Q000382:microbiology; D013297:Streptococcus pyogenes / Q000378:metabolism*; D013997:Time Factors; D014157:Transcription Factors / Q000378:metabolism / Q000502:physiology*; D014774:Virulence
chemical_list: D001426:Bacterial Proteins; D005098:Exotoxins; D014157:Transcription Factors; C027951:erythrogenic toxin; D057056:Cysteine Proteases; D005840:Gentian Violet